236 related articles for article (PubMed ID: 20813060)
1. Schizophrenia, amphetamine-induced sensitized state and acute amphetamine exposure all show a common alteration: increased dopamine D2 receptor dimerization.
Wang M; Pei L; Fletcher PJ; Kapur S; Seeman P; Liu F
Mol Brain; 2010 Sep; 3():25. PubMed ID: 20813060
[TBL] [Abstract][Full Text] [Related]
2. Action potentials and amphetamine release antipsychotic drug from dopamine neuron synaptic VMAT vesicles.
Tucker KR; Block ER; Levitan ES
Proc Natl Acad Sci U S A; 2015 Aug; 112(32):E4485-94. PubMed ID: 26216995
[TBL] [Abstract][Full Text] [Related]
3. Signaling by dopamine regulates D2 receptors trafficking at the membrane.
Tirotta E; Fontaine V; Picetti R; Lombardi M; Samad TA; Oulad-Abdelghani M; Edwards R; Borrelli E
Cell Cycle; 2008 Jul; 7(14):2241-8. PubMed ID: 18635969
[TBL] [Abstract][Full Text] [Related]
4. A dopamine D2 receptor-DISC1 protein complex may contribute to antipsychotic-like effects.
Su P; Li S; Chen S; Lipina TV; Wang M; Lai TK; Lee FH; Zhang H; Zhai D; Ferguson SS; Nobrega JN; Wong AH; Roder JC; Fletcher PJ; Liu F
Neuron; 2014 Dec; 84(6):1302-16. PubMed ID: 25433637
[TBL] [Abstract][Full Text] [Related]
5. Are dopamine D2 receptors out of control in psychosis?
Seeman P
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():146-52. PubMed ID: 23880595
[TBL] [Abstract][Full Text] [Related]
6. PAOPA, a potent dopamine D2 receptor allosteric modulator, prevents and reverses behavioral and biochemical abnormalities in an amphetamine-sensitized preclinical animal model of schizophrenia.
Beyaert MG; Daya RP; Dyck BA; Johnson RL; Mishra RK
Eur Neuropsychopharmacol; 2013 Mar; 23(3):253-62. PubMed ID: 22658400
[TBL] [Abstract][Full Text] [Related]
7. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
[TBL] [Abstract][Full Text] [Related]
8. The dopamine D1-D2 receptor heteromer localizes in dynorphin/enkephalin neurons: increased high affinity state following amphetamine and in schizophrenia.
Perreault ML; Hasbi A; Alijaniaram M; Fan T; Varghese G; Fletcher PJ; Seeman P; O'Dowd BF; George SR
J Biol Chem; 2010 Nov; 285(47):36625-34. PubMed ID: 20864528
[TBL] [Abstract][Full Text] [Related]
9. Brief exposure to obesogenic diet disrupts brain dopamine networks.
Barry RL; Byun NE; Williams JM; Siuta MA; Tantawy MN; Speed NK; Saunders C; Galli A; Niswender KD; Avison MJ
PLoS One; 2018; 13(4):e0191299. PubMed ID: 29698491
[TBL] [Abstract][Full Text] [Related]
10. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
[TBL] [Abstract][Full Text] [Related]
11. Dopamine D2High receptors measured ex vivo are elevated in amphetamine-sensitized animals.
Seeman P
Synapse; 2009 Mar; 63(3):186-92. PubMed ID: 19086090
[TBL] [Abstract][Full Text] [Related]
12. Alteration of striatal dopaminergic neurotransmission in a mouse model of DYT11 myoclonus-dystonia.
Zhang L; Yokoi F; Parsons DS; Standaert DG; Li Y
PLoS One; 2012; 7(3):e33669. PubMed ID: 22438980
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic and glutamatergic models of psychosis show differential sensitivity to aripiprazole and a novel experimental compound modulating D
Vojtechova I; Tuckova K; Juza R; Stuchlik A; Kelemen E; Korabecny J; Soukup O; Petrasek T
Prog Neuropsychopharmacol Biol Psychiatry; 2023 Dec; 127():110819. PubMed ID: 37379895
[TBL] [Abstract][Full Text] [Related]
14. Schizophrenia and dopamine receptors.
Seeman P
Eur Neuropsychopharmacol; 2013 Sep; 23(9):999-1009. PubMed ID: 23860356
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D2 Receptors Modulate Pyramidal Neurons in Mouse Medial Prefrontal Cortex through a Stimulatory G-Protein Pathway.
Robinson SE; Sohal VS
J Neurosci; 2017 Oct; 37(42):10063-10073. PubMed ID: 28912160
[TBL] [Abstract][Full Text] [Related]
16. Dopamine D2 receptors regulate the action potential threshold by modulating T-type calcium channels in stellate cells of the medial entorhinal cortex.
Jin X; Chen Q; Song Y; Zheng J; Xiao K; Shao S; Fu Z; Yi M; Yang Y; Huang Z
J Physiol; 2019 Jul; 597(13):3363-3387. PubMed ID: 31049961
[TBL] [Abstract][Full Text] [Related]
17. New Concepts in Dopamine D
Urs NM; Peterson SM; Caron MG
Biol Psychiatry; 2017 Jan; 81(1):78-85. PubMed ID: 27832841
[TBL] [Abstract][Full Text] [Related]
18. The effects in rats of lisdexamfetamine in combination with olanzapine on mesocorticolimbic dopamine efflux, striatal dopamine D2 receptor occupancy and stimulus generalization to a D-amphetamine cue.
Hutson PH; Rowley HL; Gosden J; Kulkarni RS; Slater N; Love PL; Wang Y; Heal D
Neuropharmacology; 2016 Feb; 101():24-35. PubMed ID: 26384654
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of amphetamine-mediated responses in caffeine-sensitized rats involves modifications in A2A receptors and zif-268 mRNAs in striatal neurons.
Tronci E; Simola N; Carta AR; De Luca MA; Morelli M
J Neurochem; 2006 Aug; 98(4):1078-89. PubMed ID: 16771831
[TBL] [Abstract][Full Text] [Related]
20. PET imaging of dopamine-D2 receptor internalization in schizophrenia.
Weinstein JJ; van de Giessen E; Rosengard RJ; Xu X; Ojeil N; Brucato G; Gil RB; Kegeles LS; Laruelle M; Slifstein M; Abi-Dargham A
Mol Psychiatry; 2018 Jun; 23(6):1506-1511. PubMed ID: 28507321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
